Celecoxib long-acting injectable (Arthritis Innovation Corporation/MedinCell)
塞来昔布长效注射剂 (Arthritis Innovation Corporation/MedinCell)
Report date: 2024/06/28 20:00:53
Base Information
Drug NameCelecoxib long-acting injectable (Arthritis Innovation Corporation/MedinCell)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedincell SA
China Registration ClassN/A
Develop Information
Active CompaniesArthritis Innovation Corporation
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A